Human T-lymphotropic virus type I infection

Bailliere's Best Practice and Research in Clinical Haematology

Volumn 13, Issue 2, 2000, Pages 231-243

  Tsukasaki, Kunihiro ^a   Koeffler, Phillip ^a   Tomonaga, Masao ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adult T cell leukaemia lymphoma; HTLV I related diseases; Human T lymphotropic virus type I; Subclassification of ATL

Indexed keywords

PROTEIN P16; PROTEIN P53; VIRUS DNA; VIRUS PROTEIN;

ARTICLE; BLOOD TRANSFUSION; BREAST FEEDING; CANCER CLASSIFICATION; CENTRAL AMERICA; CLINICAL FEATURE; EPIDEMIC; HUMAN; HUMAN T CELL LEUKEMIA VIRUS INFECTION; JAPAN; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCREENING TEST; SEXUAL INTERCOURSE; SEXUAL TRANSMISSION; SPASTIC PARESIS; SPINAL CORD DISEASE; T CELL LEUKEMIA; T CELL LYMPHOMA; TUMOR SUPPRESSOR GENE; UVEITIS; VIRUS CARRIER; VIRUS DNA CELL DNA INTERACTION; VIRUS EXPRESSION; VIRUS MUTATION; VIRUS TRANSMISSION;

EID: 0033693059     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1053/beha.1999.0070     Document Type: Article

References (104)

1. Adult T-cell leukemia: Clinical and hematologic features of 16 cases
2. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma
3. Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera
4. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells
5. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease
6. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis
7. HTLV-I associated myelopathy, a new clinical entity
8. HTLV-I uveitis: A distinct clinical entity caused by HTLV-I
9. Prevalence of serum and salivary antibodies to HTLV-I in Sjogren's syndrome
10. HTLV-I-associated diseases
11. Human T-lymphotropic virus type I infection
12. Human adult T-cell leukemia virus: Complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA
13. Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells
14. p27x-III and p21x-III, proteins encoded by the pX sequence of human T-cell leukemia virus type I
15. Evaluation of enzyme immunoassays for antibody to human T-lymphotropic viruses type I/II
16. A new agglutination test for serum antibodies to adult T-cell leukemia virus
17. Seroepidemiology of human T-lymphotropic retrovirus type I (HTLV-I) in residents of Niigata Prefecture, Japan. Comparative studies by indirect immunofluorescence microscopy and enzyme-linked immunosorbent assay
18. Human T cell leukemia virus (HTLV-I/II) serodiagnostic testing: Disparate results among a cohort of intravenous drug users
19. Acquired immunodeficiency syndrome (AIDS). Proposed WHO criteria for interpreting results from Western blot assays for HIV-1, HIV-2, and HTLV-I/HTLV-II
20. Human T-cell leukemia virus (HTLV-I) transcripts in fresh and cultured cells of patients with adult T-cell leukemia
21. Monocional integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease
22. A novel diagnostic method of adult T-cell leukemia: Monoclonal integration of human T-cell lymphotropic virus type I provirus DNA detected by inverse polymerase chain reaction
23. Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy
24. The detection of human T cell leukemia virus proviral DNA and its application for classification and diagnosis of T cell malignancy
25. Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia
26. Integration patterns of HTLV-I provirus in relation to the clinical course of ATL: Frequent clonal change at crisis from indolent disease
27. Frequent clonal proliferation of human T-cell leukemia virus type I (HTLV-I)-infected T-cells in HTLV-I-associated myelopathy (HAM-TSP)
28. Clinical course of human T-lymphotropic virus type I carriers with molecularly detectable monoclonal proliferation of T lymphocytes: Defining a low- and high-risk population
29. Inhibitory effect of maternal antibody on mother-to-child transmission of human T-lymphotropic virus type I
30. Demonstration of adult T-cell leukemia virus antigen in milk from three sero-positive mothers
31. Primary prevention of HTLV-I in Japan
32. Epidemiological analysis of the distribution of antibody to adult T-cell leukemia-virus-associated antigen: Possible horizontal transmission of adult T-cell leukemia virus
33. A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: Seroconversion in recipients
34. Prevalence and epidemiologic correlates of human T cell lymphotropic virus infection among intravenous drug users
35. Antibodies to HTLV-I p24 in sera of blood donors, elderly people and patients with hemopoietic diseases in France and in French West Indies
36. Antibodies to ATLV/HTLV-I in Africa
37. Prevalence of antibodies to human T-cell leukemia/lymphoma virus type I and human immunodeficiency virus in Japanese immigrant colonies in Bolivia and Bolivian natives
38. Spastic paraparesis associated with human T-lymphotropic virus type I: A clinical, serological, and genomic study in Iranian-born Mashhadi Jews
39. Human T lymphotropic virus type I infection in Papua New Guinea: High prevalence among the Hagahai confirmed by Western analysis
40. Tropical spastic paraparesis and human T cell lymphotropic virus type I in the United Kingdom
41. Epidemiological features of HTLV-I carriers and incidence of ATL in an ATL-endemic island: A report of the community-based co-operative study in Tsushima, Japan
42. Findings from the Miyazaki Cohort study
43. Infective dermatitis of Jamaican children: A marker for HTLV-I infection
44. HTLV-I and polymyositis in Jamaica
45. T-lymphocyte alveolitis in HTLV-I-associated myelopathy
46. Chronic inflammatory arthropathy associated with HTLV-I
47. HTLV-I-associated myelopathy (HAM/TSP) with Hashimoto's thyroiditis
48. Suppression of tuberculin skin reaction in healthy HTLV-I carriers from Japan
49. Major prognostic factors of patients with adult T-cell leukemia- lymphoma: A cooperative study
50. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma
51. Prognostic significance of the proportion of Ki-67-positive cells in adult T-cell leukemia
52. Phenotypic diversity and prognosis of adult T-cell leukemia
53. Deletions of p15 and/or p16 genes as a poor-prognosis factor in adult. T-cell leukemia
54. Statistical analyses of clinico-pathological, virological and epidemiological data on lymphoid malignancies with special reference to adult T-cell leukemia/lymphoma: A report of the second nationwide study of Japan
55. Racial and other characteristics of human T cell leukemia/lymphoma (HTLV-I) and AIDS (HTLV-III) in Trinidad
56. Clustering and clinical diversity of adult T-cell leukemia/lymphoma associated with HTLV-I in a remote black population of French Guiana
57. Estimation of rate of incidence of ATL among ATLV (HTLV-I) carriers in Kyushu, Japan
58. Risk of adult T-cell leukaemia/lymphoma in HTLV-I carriers
59. Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I
60. Patterns of HTLV-I infection among family members of patients with adult T-cell leukemia/lymphoma and HTLV-I associated myelopathy/tropical spastic paraparesis
61. Nationwide survey of HTLV-I-associated myelopathy in Japan: Association with blood transfusion
62. Infection of human T-cell leukemia virus type I and development of human T-cell leukemia lymphoma in patients with hematologic neoplasms: A possible linkage to blood transfusion
63. Adult T-cell leukemia with HTLV-I-associated myelopathy after complete remission of acute myelogenous leukemia
64. Age- and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers
65. Unusual clinical courses of adult T-cell leukemia in siblings
66. Smoking and adult T-cell leukemia/lymphoma
67. Infective dermatitis among patients with ATL in Japan
68. Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I
69. HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: Comparison with adult T-cell leukemia/lymphoma
70. Multi-step carcinogenesis model for adult T-cell leukemia
71. Nonspecific integration of the HTLV provirus genome into adult T-cell leukaemia cells
72. Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I
73. Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type I
74. Transactivation of the human interleukin-6 gene by human T-lymphotropic virus type I Tax protein
75. Activation of T cell-derived lymphokine genes in T cells and fibroblasts: Effects of human T cell leukemia virus type I p40x protein and bovine papilloma virus encoded E2 protein
76. c-fos promoter trans-activation by the tax1 protein of human T-cell leukemia virus type I
77. Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type I (HTLV-I) carriers and adult cell leukemia patients that can be trans-activated by HTLV-I tax gene
78. Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction
79. + cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease
80. Mutations of the p53 gene in adult T-cell leukemia
81. Mutation of CD95 (Fas/Apo-I) gene in adult T-cell leukemia cells
82. Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomas
83. High rate of chromosomal abnormalities in HTLV-I-infected T-cell colonies derived from prodromal phase of adult T-cell leukemia: A study of IL-2-stimulated colony formation in methylcellulose
84. A proposal for smoldering adult T-cell leukemia: A clinicopathologic study of five cases
85. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias
86. Diversity of leukaemic cell morphology in ATL correlates with prognostic factors, aberrant immunophenotype and defective HTLV-I genotype
87. HTLV-positive and -negative T-cell lymphomas. Morphological and immunohistochemical differences between European and HTLV-positive Japanese T-cell lymphomas
88. Adult T-cell leukemia lymphoma
89. Frequency of eosinophilia in adult T-cell leukemia/lymphoma
90. Possible mechanisms for the elevation of serum beta 2-microglobulin levels in adult T-cell leukemia
91. Chromosome abnormalities in adult T-cell leukemia/lymphoma: A karyotype review committee report
92. T-cell malignancies in Brazil. Clinico-pathological and molecular studies of HTLV-I-positive and -negative cases
93. Management of adult T-cell leukaemia/lymphoma
94. Characteristics of chemotherapy-induced clinical remission in long survivors with aggressive adult T-cell leukemia/lymphoma
95. Expression of P-glycoprotein in adult T-cell leukemia cells
96. Combination chemotherapy (RCM protocol: Response-oriented cyclic multidrug protocol) for the acute or lymphoma type adult T-cell leukemia
97. An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support
98. Poor outcome of autologous stem cell transplantation for adult T cell leukemia/lymphoma: A case report and review of the literature
99. Allogenic bone marrow transplantation as a treatment for adult T-cell leukemia
100. The interleukin-2 receptor: A target for monoclonal antibody treatment of human T-cell lymphotropic virus I-induced adult T-cell leukemia
101. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine
102. + ATPase